Gilead Sciences Highlights Strategies to Achieve Global HCV Elimination

Gilead actively supports the efforts of governments and partners with professional organizations, patient advocacy groups, payers and healthcare professionals who have declared their intention and commitment to work toward the WHO goal of elimination of viral hepatitis around the world by 2030.

Available at this link is a poster presented at International Viral Hepatitis Elimination Meeting (IVHEM), held on November 17-18 in Amsterdam, The Netherlands, capturing the various ways in which Gilead has supported hepatitis C virus (HCV) elimination programs around the world.

At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.